🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT06355206
Recruiting Observational

Natural Course and Therapeutic Effect of Recurrent Acute Pancreatitis

NCT06355206 · tracked via the Priya Life Science China tracker
Sponsor
Changhai Hospital
Phase
Observational
Started
2024-04-22
Last updated
2024-05-09

Condition(s) studied

Cohort StudyRecurrent Acute Pancreatitis

Investigational drug(s) / intervention(s)

endoscopic intervention, surgery or conservative treatment

endoscopic intervention, surgery or conservative treatment: Personal information and treatment of the enrolled subjects will be collected.

Study summary

The goal of this observational cohort study is to learn about the etiology, natural course, therapeutic effect and outcome of recurrent acute pancreatitis patients. The main question it aims to answer is:

Does endoscopic intervention, surgery or conservative treatment reduce the recurrence of acute pancreatitis? What are the risk factors affecting the recurrence of acute pancreatitis?

Patients will be closely followed and clinical information will be recorded.

Eligibility

Sex
ALL
Min age
Max age
Healthy volunteers
No
Inclusion Criteria: * Patients with recurrent acute pancreatitis. Exclusion Criteria: * Unwilling or unable to provide consent.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Changhai Hospital Shanghai Shanghai Municipality Recruiting

More Changhai Hospital trials in China

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06355206 on ClinicalTrials.gov ↗ ← All trials in China